Goldman Sachs’s Inspire Corporate Bond ETF IBD Stock Holding History
Bought
Maintained
Sold
Other funds holding IBD
IA
FA
CFD
II
BFS
OFS
CW
PFG
PAW
Goldman Sachs's IBD Position: Q1 2026 in Review
Goldman Sachs increased its Inspire Corporate Bond ETF (IBD) stake by 896% in Q1 2026, buying an estimated $4.34M and bringing the position to 200,001 shares worth $4.77M. The position accounts for ﹤0.01% of the portfolio, ranked #3743.
Goldman Sachs first reported a position in IBD in Q3 2022 and has held it in 6 quarters since. 106 funds tracked by Wall St. Rank hold IBD as of Q1 2026.
- Goldman Sachs held 200,001 shares of Inspire Corporate Bond ETF worth $4.77M as of Q1 2026.
- Goldman Sachs bought 179,914 Inspire Corporate Bond ETF shares in Q1 2026, an estimated $4.34M.
- Inspire Corporate Bond ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3743 holding.
- Goldman Sachs first reported a position in Inspire Corporate Bond ETF in Q3 2022 and has held it in 6 quarters since.
- 106 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.